CASI Pharmaceuticals, Inc. (CASI)
NASDAQ: CASI · Real-Time Price · USD
5.25
+0.03 (0.57%)
Nov 21, 2024, 3:41 PM EST - Market closed
CASI Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 79 | 95 | 24 | 112 | 366 | 298 | |
| Market Cap Growth | 171.82% | 291.63% | -78.22% | -69.41% | 22.82% | -22.28% | |
| Enterprise Value | 77 | 81 | 17 | 76 | 313 | 257 | |
| Last Close Price | 5.26 | 7.16 | 1.79 | 8.00 | 29.50 | 30.90 | |
| PS Ratio | 3.31 | 2.82 | 0.56 | 3.71 | 24.15 | 72.07 | |
| PB Ratio | 5.81 | 3.95 | 0.36 | 1.04 | 3.53 | 3.18 | |
| P/TBV Ratio | 7.28 | 4.27 | 0.56 | 1.55 | 5.35 | 5.02 | |
| EV/Sales Ratio | 3.51 | 2.40 | 0.40 | 2.51 | 20.66 | 62.16 | |
| Debt / Equity Ratio | 1.38 | 0.88 | 0.02 | 0.02 | 0.03 | 0.02 | |
| Asset Turnover | 0.32 | 0.40 | 0.37 | 0.23 | 0.13 | 0.04 | |
| Inventory Turnover | 0.93 | 1.26 | 3.93 | 7.70 | 3.22 | 1.63 | |
| Quick Ratio | 2.17 | 2.45 | 3.78 | 4.43 | 8.90 | 6.99 | |
| Current Ratio | 3.20 | 3.55 | 4.32 | 4.70 | 9.28 | 8.14 | |
| Return on Equity (ROE) | -95.77% | -57.65% | -46.04% | -33.89% | -48.18% | -44.66% | |
| Return on Assets (ROA) | -28.68% | -18.43% | -14.12% | -16.55% | -18.08% | -22.90% | |
| Return on Capital (ROIC) | -47.39% | -27.80% | -18.56% | -20.30% | -20.55% | -23.92% | |
| Earnings Yield | -39.12% | -28.24% | -168.40% | -32.77% | -13.21% | -15.46% | |
| FCF Yield | -21.15% | -109.63% | -32.00% | -7.49% | -7.95% | |
| Buyback Yield / Dilution | -3.62% | 2.10% | -0.27% | -23.23% | -15.12% | -13.21% | |
| Total Shareholder Return | -3.62% | 2.10% | -0.27% | -23.23% | -15.12% | -13.21% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.